Acute myeloid leukemia with 11q23-abnormality in relapse is a hematological malignancy characterized by the proliferation of myeloid cells with a specific chromosomal abnormality. This condition is clinically significant due to its aggressive nature and poor prognosis. Accurate coding with ICD-10 Code C92.62 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C92.62 represents Acute myeloid leukemia with 11q23-abnormality in relapse, indicating a recurrence of this specific type of leukemia characterized by genetic abnormalities. This code should be used in clinical documentation and billing when a patient presents with relapsed symptoms following initial treatment, ensuring accurate representation of the patient's condition for healthcare providers and payers.
Acute myeloid leukemia with 11q23-abnormality in relapse is a severe form of leukemia that arises from the malignant transformation of myeloid progenitor cells, often associated with poor outcomes. The 11q23 chromosomal abnormality is linked to specific genetic mutations that contribute to the disease's aggressiveness. Prompt medical attention is crucial due to the rapid progression of the disease.
ICD-10 Code C92.62 is utilized in SOAP notes to document the patient's symptoms, assessment, and treatment plan for Acute myeloid leukemia with 11q23-abnormality in relapse. This code is relevant in both acute and chronic care settings, facilitating clear communication among healthcare providers and ensuring appropriate management of the patient's condition.
In SOAP notes, ICD-10 Code C92.62 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Acute myeloid leukemia with 11q23-abnormality in relapse. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Acute myeloid leukemia with 11q23-abnormality in relapse requires urgent intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.62 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85027 | Complete blood count with differential. |
| 38221 | Bone marrow aspiration and/or biopsy. |
| 96413 | Chemotherapy administration, intravenous, push. |
| 99223 | Initial hospital care, typically 70 minutes. |
Common Questions About Using ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse
What are the common symptoms of Acute myeloid leukemia with 11q23-abnormality in relapse?
Common symptoms include fatigue, fever, easy bruising or bleeding, and recurrent infections. Patients may also experience weight loss and night sweats.
How is Acute myeloid leukemia with 11q23-abnormality in relapse treated?
Treatment typically involves intensive chemotherapy, and in some cases, stem cell transplantation may be considered. Supportive care is also crucial to manage symptoms and complications.
When should ICD-10 Code C92.62 be used?
This code should be used when documenting a relapse of Acute myeloid leukemia with 11q23-abnormality, particularly after a previous treatment regimen.
What is the prognosis for patients with this condition?
The prognosis for Acute myeloid leukemia with 11q23-abnormality in relapse is generally poor, with a high risk of complications and a lower likelihood of long-term remission compared to other forms of leukemia.
Clinical Notes
SOAP notes
DAP notes
AI medical notes